The US Food and Drug Administration (FDA) is now “open to bayesian statistics,” contrasting this with the frequentist approach that the agency and the drug industry have historically relied on for ...
If the FDA follows through with the proposed guidelines, and they are not fatally twisted by pressure from the medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results